We are glad to announce that Morgan Stanley Private Equity Asia and the promoters of ClearMedi Healthcare Pvt Ltd (“ClearMedi”) have acquired 100% equity stake in ClearMedi from Italy’s KOS Group. The transaction is the first of its kind private equity backed management buy-outs to provide exit to an international strategic player in the oncology space in India.
Advay Capital Advisors Private Limited (“Advay”) was the exclusive financial advisor to ClearMedi and the operating promoter team for the transaction that involved both identifying and structuring a deal with a private equity partner as well as advising the acquirers to provide exit to the existing international strategic player. Advay provided transaction advisory services involving positioning the opportunity to a relevant list of leading private equity funds, generating offers through a tightly run process under extremely tight timelines, driving comprehensive financial, legal & other diligence exercises, leading negotiations, managing stakeholder interests, valuation and transaction structuring and leading negotiations on the definitive agreements resulting in a successful transaction closure.
“The Advay team comes with in-depth knowledge of the healthcare space and were able to find the right private equity partner for this transaction under extremely tight timelines. This transaction was especially challenging since it involved multiple stakeholders including the exiting international strategic group and an incoming globally well-known private equity fund. We had a great experience with the Advay team as they navigated the intricacies of the transaction and provided solutions all through the transaction process. I would recommend them for their commitment and unbiased advice and ability to close complex deals with global counterparties." - Dr. Shashi Kant Baliyan, Promoter of ClearMedi.
The deal further strengthens Advay team’s track record in Healthcare Transaction Advisory having concluded many of the largest deals in the space extending coverage across multiple geographies and specialties.
Some of the marquee healthcare delivery transactions advised exclusively by the Advay team include:
-
Sale of 100% stake in RGS Healthcare Ltd in one of the largest deals for a multi-specialty hospital in the state of Punjab.
-
Sale of controlling stake in Aurangabad based CIIGMA Group of Hospitals to TPG backed CARE Hospitals
-
Majority investment in the largest hospital chain in Western India, Sahyadri Hospitals by Everstone Capital for USD ~145 Mn,
-
Sale of premium 600 bedded hospital in NCR region to a leading hospital chain,
-
Majority investment in the largest hospital chain in Eastern India, Medica Synergie by Temasek backed Sheares Healthcare Group for USD ~100 mn,
-
Private equity of USD 210+ Mn over 3 separate Private equity rounds by Aster DM Healthcare,
-
Majority stake sale by Lucknow based Medics International Lifesciences to Apollo Hospitals,
-
Sale of majority stake in Global Hospitals to the 2nd largest hospital chain in the world, IHH Healthcare Berhad,
-
PE raise of USD ~50 Mn by Dr Agarwal’s Eye Hospital – India’s largest eye care chain,
-
Private equity raise by Dr Mohan’s Diabetes Specialities – India's No. 1 Diabetes care provider,
-
Sale of majority stake in Hyderabad based Continental Hospitals to IHH Healthcare Berhad.
